These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24963470)
1. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. Lee H; Kong SY; Sohn JY; Shim H; Youn HS; Lee S; Kim HJ; Eom HS Biomed Res Int; 2014; 2014():145619. PubMed ID: 24963470 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Elevated Red Blood Cell Distribution Width in Chinese Patients with Multiple Myeloma. Meng S; Ma Z; Lu C; Liu H; Tu H; Zhang W; Zhou F Ann Clin Lab Sci; 2017 May; 47(3):282-290. PubMed ID: 28667028 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of pretreatment red cell distribution width in patients with multiple myeloma. Wang J; Xie X; Cheng F; Zhou X; Xia J; Qian X; Wang L; Guo H Cancer Biomark; 2017 Sep; 20(3):267-272. PubMed ID: 28826172 [TBL] [Abstract][Full Text] [Related]
4. Assessment of Red Blood Cell Distribution Width and Multiple Myeloma in a Guangxi Population: a Retrospective Study. Huang C; Wei H; Lan F; Lu Y; Li S; Qin X Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868861 [TBL] [Abstract][Full Text] [Related]
5. Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma. Zhou D; Xu P; Peng M; Shao X; Wang M; Ouyang J; Chen B Clin Chim Acta; 2018 Jun; 481():34-41. PubMed ID: 29452082 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic Value of Red Blood Cell Distribution Width in Senile Potients with Non-trans planted Multiple Myeloma]. Sun C; Ye JN; Wang H; Zhu JW; Zhou X; Li JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):115-122. PubMed ID: 30738457 [TBL] [Abstract][Full Text] [Related]
7. The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma. Sarı M; Sarı S; Nalçacı M Turk J Haematol; 2017 Jun; 34(2):131-136. PubMed ID: 27795224 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer. Tham T; Olson C; Wotman M; Teegala S; Khaymovich J; Coury J; Costantino P Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2869-2878. PubMed ID: 30251123 [TBL] [Abstract][Full Text] [Related]
9. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I. Gastinne T; Leleu X; Duhamel A; Moreau AS; Franck G; Andrieux J; Lai JL; Coiteux V; Yakoub-Agha I; Bauters F; Harousseau JL; Zandecki M; Facon T; Eur J Haematol; 2007 Oct; 79(4):297-304. PubMed ID: 17692103 [TBL] [Abstract][Full Text] [Related]
10. Elevated red cell distribution width contributes to a poor prognosis in patients with esophageal carcinoma. Wan GX; Chen P; Cai XJ; Li LJ; Yu XJ; Pan DF; Wang XH; Wang XB; Cao FJ Clin Chim Acta; 2016 Jan; 452():199-203. PubMed ID: 26633854 [TBL] [Abstract][Full Text] [Related]
11. Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma. Miao Y; Zhou XH; Guo JJ; Sun Q; Shi K; Wu JZ; Zhu HY; Wang L; Fan L; Xu W; Li JY Cancer Med; 2019 Jun; 8(6):2751-2758. PubMed ID: 30980510 [TBL] [Abstract][Full Text] [Related]
12. Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients. Ghermezi M; Li M; Vardanyan S; Harutyunyan NM; Gottlieb J; Berenson A; Spektor TM; Andreu-Vieyra C; Petraki S; Sanchez E; Udd K; Wang CS; Swift RA; Chen H; Berenson JR Haematologica; 2017 Apr; 102(4):785-795. PubMed ID: 28034989 [TBL] [Abstract][Full Text] [Related]
13. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. Koma Y; Onishi A; Matsuoka H; Oda N; Yokota N; Matsumoto Y; Koyama M; Okada N; Nakashima N; Masuya D; Yoshimatsu H; Suzuki Y PLoS One; 2013; 8(11):e80240. PubMed ID: 24244659 [TBL] [Abstract][Full Text] [Related]
15. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients. Li M; Xia H; Zheng H; Li Y; Liu J; Hu L; Li J; Ding Y; Pu L; Gui Q; Zheng Y; Zhai Z; Xiong S BMC Cancer; 2019 Nov; 19(1):1084. PubMed ID: 31711453 [TBL] [Abstract][Full Text] [Related]
16. Relationship between red cell distribution width and prognosis of patients with osteosarcoma. Zheng J; Yuan X; Guo W Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31815279 [TBL] [Abstract][Full Text] [Related]
17. Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics. Vagnoni D; Travaglini F; Pezzoni V; Ruggieri M; Bigazzi C; Dalsass A; Mestichelli F; Troiani E; Falcioni S; Mazzotta S; Natale A; Angelini M; Ferretti S; Angelini S; Galieni P Br J Haematol; 2015 Aug; 170(4):523-31. PubMed ID: 26010293 [TBL] [Abstract][Full Text] [Related]
18. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count. Perosa F; Minoia C; Favoino E; Prete M; Dammacco F Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035 [TBL] [Abstract][Full Text] [Related]
19. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer. Cheng S; Han F; Wang Y; Xu Y; Qu T; Ju Y; Lu Z BMC Gastroenterol; 2017 Dec; 17(1):163. PubMed ID: 29262773 [TBL] [Abstract][Full Text] [Related]
20. Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Greipp PR; Lust JA; O'Fallon WM; Katzmann JA; Witzig TE; Kyle RA Blood; 1993 Jun; 81(12):3382-7. PubMed ID: 8507875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]